journal article·2019Open access

Engineering a stable future for DNA-origami as a biomaterial

Hale Bila, Eva E. Kurisinkal, Maartje M. C. Bastings

Biomaterials Science· Volume 7· Issue 2

Abstract

DNA as a biomaterial has evoked great interest as a potential platform for therapeutics and diagnostics and as hydrogel scaffolds due to the relative ease of programming its robust and uniform shape, site-specific functionality and controlled responsive behavior. However, for a stable self-assembled product, a relatively high cation concentration is required to prevent denaturation. Physiological and cell-culture conditions do not match these concentrations and present additional nucleases that cause a serious threat to the integrity of DNA-based materials. For the translation of this promising technology towards bioengineering challenges, stability needs to be guaranteed. Over the past years, various methods have been developed addressing the stability-related weaknesses of DNA-origami. This mini-review explains the common stability issues and compares the stabilization strategies recently developed. We present a detailed overview of each method in order to ease the selection process on which method to use for future users of DNA-origami as a biomaterial.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Programmable Biomaterials Laboratory (PBL)

Institute of Materials (IMX)/Interfaculty Bioengineering Institute (IBI)

School of Engineering (STI)

École Polytechnique Federale de Lausanne (EPFL)

Lausanne

References (71)

Show source-provided references
1. Langer · Nature · 2004 · 428 · 48710.1038/nature02388 ↗
2. Blum · J. Am. Chem. Soc. · 2015 · 137 · 214010.1021/ja510147n ↗
3. von Maltzahn · Nat. Mater. · 2011 · 10 · 54510.1038/nmat3049 ↗
4. Oh · Int. J. Nanomed. · 2014 · 9 · 51
5. Moon · Nat. Mater. · 2011 · 10 · 24310.1038/nmat2960 ↗
6. Říhová · Adv. Drug Delivery Rev. · 2002 · 54 · 65310.1016/S0169-409X(02)00043-1 ↗
7. Sahdev · Pharm. Res. · 2014 · 31 · 256310.1007/s11095-014-1419-y ↗
8. Unfried · Nanotoxicology · 2007 · 1 · 5210.1080/00222930701314932 ↗
9. Marano · Arch. Toxicol. · 2011 · 85 · 73310.1007/s00204-010-0546-4 ↗
10. Kah · Crit. Rev. Biomed. Eng. · 2013 · 41 · 32310.1615/CritRevBiomedEng.2014010490 ↗
11. Ragelle · Expert Opin. Drug Delivery · 2017 · 14 · 85110.1080/17425247.2016.1244187 ↗
12. Williams · Biotechnol. J. · 2014 · 9 · 33710.1002/biot.201300120 ↗
13. Seeman · Annu. Rev. Biochem. · 2010 · 79 · 6510.1146/annurev-biochem-060308-102244 ↗
14. Seeman · Nat. Rev. Mater. · 2018 · 3 · 1706810.1038/natrevmats.2017.68 ↗
15. Wagenbauer · ChemBioChem · 2017 · 18 · 187310.1002/cbic.201700377 ↗
16. Hong · Chem. Rev. · 2017 · 117 · 1258410.1021/acs.chemrev.6b00825 ↗
17. Nummelin · Adv. Mater. · 2018 · 30 · 170372110.1002/adma.201703721 ↗
18. Praetorius · Nature · 2017 · 552 · 8410.1038/nature24650 ↗
19. Hu · Chem. Rev. · 201810.1021/acs.chemrev.7b00663 ↗
20. Madhanagopal · Trends Biochem. Sci. · 2018 · 43 · 99710.1016/j.tibs.2018.09.010 ↗
21. Kielar · Angew. Chem., Int. Ed. · 2018 · 57 · 947010.1002/anie.201802890 ↗
22. Hahn · ACS Nano · 2014 · 8 · 876510.1021/nn503513p ↗
23. Rothemund · Nature · 2006 · 440 · 29710.1038/nature04586 ↗
24. Ramakrishnan · Comput. Struct. Biotechnol. J. · 2018 · 16 · 34210.1016/j.csbj.2018.09.002 ↗
25. Jiang · Nano Res. · 2015 · 8 · 217010.1007/s12274-015-0724-z ↗
26. Mei · Nano Lett. · 2011 · 11 · 147710.1021/nl1040836 ↗
27. Perrault · ACS Nano · 2014 · 8 · 513210.1021/nn5011914 ↗
28. Ahmadi · Nanoscale · 2018 · 10 · 749410.1039/C7NR09461B ↗
29. Jungmann · Nat. Methods · 2014 · 11 · 31310.1038/nmeth.2835 ↗
30. Ponnuswamy · Nat. Commun. · 2017 · 8 · 1565410.1038/ncomms15654 ↗
31. Jahnen-Dechent · Clin. Kidney J. · 2012 · 5 · i310.1093/ndtplus/sfr163 ↗
32. McKee · Am. J. Physiol.: Cell Physiol. · 2017 · 312 · C62410.1152/ajpcell.00336.2016 ↗
33. Hu · Drug Delivery · 2017 · 24 · 129510.1080/10717544.2017.1373166 ↗
34. Gerling · Sci. Adv. · 2018 · 4 · eaau115710.1126/sciadv.aau1157 ↗
35. Cherepanova · J. Immunol. Methods · 2007 · 325 · 9610.1016/j.jim.2007.06.004 ↗
36. Mikkilä · Nano Lett. · 2014 · 14 · 219610.1021/nl500677j ↗
37. Auvinen · Adv. Healthcare Mater. · 2017 · 6 · 170069210.1002/adhm.201700692 ↗
38. Hernandez-Garcia · ACS Nano · 2017 · 11 · 14410.1021/acsnano.6b05938 ↗
39. Agarwal · Angew. Chem., Int. Ed. · 2017 · 56 · 546010.1002/anie.201608873 ↗
40. Bastings · Nano Lett. · 2018 · 18 · 355710.1021/acs.nanolett.8b00660 ↗
41. Fischer · Pharm. Res. · 1999 · 16 · 127310.1023/A:1014861900478 ↗
42. Fischer · Biomaterials · 2003 · 24 · 112110.1016/S0142-9612(02)00445-3 ↗
43. Cerda-Cristerna · J. Controlled Release · 2011 · 153 · 26910.1016/j.jconrel.2011.04.016 ↗
44. Chopra · Nano Lett. · 2016 · 16 · 668310.1021/acs.nanolett.6b03586 ↗
45. Wang · ACS Appl. Mater. Interfaces · 2018 · 10 · 1550410.1021/acsami.8b03464 ↗
46. O'Neill · Nano Lett. · 2006 · 6 · 137910.1021/nl0603505 ↗
47. Rajendran · J. Am. Chem. Soc. · 2011 · 133 · 1448810.1021/ja204546h ↗
48. Cassinelli · Angew. Chem., Int. Ed. · 2015 · 54 · 779510.1002/anie.201500561 ↗
49. De Stefano · ChemBioChem · 2016 · 17 · 112210.1002/cbic.201600076 ↗
50. Hwang · Science · 1992 · 257 · 149610.1126/science.1523409 ↗
51. Gordon · Radiat. Res. · 1982 · 89 · 9910.2307/3575688 ↗
52. Oligo modifications that block nuclease degradation [Internet]. [cited 2018 Oct 5]. Available from: https://eu.idtdna.com/pages/education/decoded/article/modification-highlight-modifications-that-block-nuclease-degradationss
53. Fisher · Nucleic Acids Res. · 1993 · 21 · 385710.1093/nar/21.16.3857 ↗
54. Eckstein · Trends Biochem. Sci. · 1989 · 14 · 9710.1016/0968-0004(89)90130-8 ↗
55. Ciafrè · Nucleic Acids Res. · 1995 · 23 · 413410.1093/nar/23.20.4134 ↗
56. Putney · Proc. Natl. Acad. Sci. U. S. A. · 1981 · 78 · 735010.1073/pnas.78.12.7350 ↗
57. Drygin · Nucleic Acids Res. · 2004 · 32 · 658510.1093/nar/gkh997 ↗
58. Yoo · Nucleic Acids Res. · 2004 · 32 · 200810.1093/nar/gkh516 ↗
59. Ortigão · Antisense Res. Dev. · 1992 · 2 · 12910.1089/ard.1992.2.129 ↗
60. Shaw · Nucleic Acids Res. · 1991 · 19 · 74710.1093/nar/19.4.747 ↗
61. Eder · Antisense Res. Dev. · 1991 · 1 · 14110.1089/ard.1991.1.141 ↗
62. Liu · ChemPhysChem · 2017 · 18 · 297710.1002/cphc.201700809 ↗
63. Conway · Chem. Commun. · 2013 · 49 · 117210.1039/c2cc37556g ↗
64. Bujold · J. Am. Chem. Soc. · 2016 · 138 · 1403010.1021/jacs.6b08369 ↗
65. Bujold · Chem. Sci. · 2014 · 5 · 244910.1039/C4SC00646A ↗
66. Lacroix · J. Am. Chem. Soc. · 2017 · 139 · 735510.1021/jacs.7b02917 ↗
67. Ramakrishnan · Small · 2017 · 13 · 170210010.1002/smll.201702100 ↗
68. Li · Angew. Chem., Int. Ed. · 2018 · 57 · 689210.1002/anie.201804054 ↗
69. Yang · Biochim. Biophys. Acta · 2014 · 1845 · 84
70. Chang · ACS Nano · 2011 · 5 · 615610.1021/nn200693a ↗
71. Zhu · NPG Asia Mater. · 2015 · 7 · e16910.1038/am.2015.19 ↗